FMP
Forte Biosciences, Inc.
FBRX
NASDAQ
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
15.6 USD
-0.2 (-1.28%)
We are unable to load this data!
We are unable to load the data!